monsanto boa_tkc_04-30-08
DESCRIPTION
TRANSCRIPT
1
TERRY CREWS
CHIEF FINANCIAL OFFICER
BANK OF AMERICA
2008 BASICS/INDUSTRIALS CONFERENCE
May 8, 2008
Forward-Looking Statements
2
Certain statements contained in this presentation are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent reports on forms 10-Q and 10-K. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this presentation. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.
TrademarksTrademarks owned by Monsanto Company and its wholly-owned subsidiaries are italicized in this presentation. All other trademarks are the property of their respective owners.
© 2008 Monsanto Company
Non-GAAP Financial Information
This presentation may use the non-GAAP financial measures of “free cash flow,” and earnings per share (EPS) on
an ongoing basis. We define free cash flow as the total of cash flows from operating activities and investing
activities. A non-GAAP EPS financial measure, which we refer to as on-going EPS, excludes certain after-tax items
that we do not consider part of ongoing operations, which are identified in the reconciliation. Our presentation of
non-GAAP financial measures is intended to supplement investors’ understanding of our operating performance.
These non-GAAP financial measures are not intended to replace net income (loss), cash flows, financial position, or
comprehensive income (loss), as determined in accordance with accounting principles generally accepted in the
United States. Furthermore, these non-GAAP financial measures may not be comparable to similar measures used
by other companies. The non-GAAP financial measures used in this presentation are reconciled to the most
directly comparable financial measures calculated and presented in accordance with GAAP, which can be found at
the end of this presentation.
3
With Opportunities in Hand, Monsanto Has Potential to More
Than Double 2007 Gross Profit Over Next Five Years
OVERVIEW
$0
$2,000
$4,000
$6,000
$8,000
$10,000
2007 2008F 2012F
Seeds & Genomics
Roundup And Other Glyphosate-based Herbicides
All Other Agricultural Productivity
IN
M
ILLIO
NS
GROSS PROFIT OUTLOOK BY SEGMENT
2007-2012F
2012 GROWTH RANGE
Gross profit targeted to more than double from 2007 through 2012 including recent lift in Roundup to $1.8B gross profit
STRATEGIC PLAYBOOK
All growth is organic, from
base business and pipeline
U.S. Corn International Corn Soybeans Cotton Vegetables R&D Pipeline
Earnings continue to translate into operating cash
>2X2007 BASELINE
Increased in Q2 2008 for
new Roundup target
On Track to More Than Double Gross Profit From 2007 to 2012, Growth Drivers Roll Out In Balanced Progression
OVERVIEW
GROSS PROFIT TARGET:
NEAR $9B IN 2012
2008 2009 2010 2011 2012
U.S. Corn
International Corn
Soybean
2009
Roundup Ready 2
Yield soybeans
controlled
commercial release
Cotton
2010
U.S. SmartStax
corn launch
Large-scale
Roundup Ready 2
Yield soybean
launch
MIL
ES
TO
NE
S
Seminis
R&D Pipeline
• Trait penetration and seed share growth• SmartStax platformDRIVERS:
• Seed share growth• New trait approvals in LADRIVERS:
• Roundup Ready 2 Yield platform• Seed share growth
DRIVERS:
• 2nd-gen trait acceleration• Breeding inroads
DRIVERS:
• Protected culture• Molecular markers
DRIVERS:
• Yield & stress platform• Breakthrough platforms
DRIVERS:
• From 2007 baseline: $4.2B
• 2012 target increased by almost 10% in Q2 2008 on incremental 2012 Roundup expectations
2008 to 2012 Projected branded corn share gains globally
2012+
U.S. drought-
tolerant corn launch
2011-2012
Delta and Pine
Land U.S.
portfolio
converted to
second-
generation stack
2012+
Stacked trait
soybean launches,
including dedicated
product for Brazil
First major selling
season for LA corn
traits
5
6
OVERVIEW
Strong Cash Position Gives Monsanto the Resources to Extend Its Competitive Lead
$1,000
$1,200
$1,400
$1,600
$1,800
$2,000
$2,200
$2,400
$2,600
2003 2004 2005 2006 2007 2008F
$0.50
$1.00
$1.50
$2.00
$2.50
$3.00
$3.50
Operating Cash
Ongoing EPS
Cash
fro
m O
pera
tio
ns
(in
$ t
ho
usan
ds) O
ng
oin
g E
PS
MONSANTO’S FINANCIAL INDICATORS:
OPERATING CASH AND ONGOING EPS – 2003 TO 2008F Cash Generation
Strong cash generation
allows Monsanto to invest to
extend its competitive lead:
Bolster direct returns to
shareowners
Support commercial growth
through capital spending
Invest in future growth
through R&D
Expand the core through
strategic acquisitions
2008F
Monsanto operating cash guidance exceeds $2B, as net income grows
2003-2006
>$1B in Working Capital reductions used to fund key acquisitions like Seminis and ASI
7
OVERVIEW
Over Last Three Years, Use of Cash Focused on Areas That Contribute to Growth and Return Value to Shareowners
USES OF CASH
CUMULATIVE: 2005-2007
$1,160
$266
$545
$639
$3,161
ACQUISITIONS 55% OF CASH USED
• American Seeds, Inc.
(2004-2007)
• Seminis (2005)
• Delta & Pine Land (2007)
• Agroeste (2007)
CAPITAL SPENDING 20% OF CASH USED
• Beginning of 3-year, $610M plan to expand corn seed
production
SHARE REPURCHASES 9% OF CASH USED
• Initiated 4-year $800M share-repurchase program in October
2005$ in thousands
DIVIDENDS 11% OF CASH USED
• Increased dividends 3 times during this period, for a
cumulative increase of 106%
TECHNOLOGY SPENDING 5% OF CASH USED
• Nearly $150M spent to expand technology partnership
network
RETURNING VALUE TO SHAREOWNERS
MONSANTO ANNUAL SHARE REPURCHASE:
2003-2007
Share Repurchases
STATUS
• 54% through 4-year $800M program begun in October 2005
• Focus areas in 2008:• In April, announced
acceleration of current program and new 3-year $800M authorization
Newly Authorized Program Accelerates and Extends Monsanto’s Share-Repurchase Initiative
8
$0
$50
$100
$150
$200
$250
$300
2004 2005 2006 2007
2004-2005
3-year $500M repurchase program – completed early
$ in
millio
ns
2006 FORWARD
• 4-year $800M repurchase program initiated in October 2005
• 2008 Update: Accelerated and added new program
RETURNING VALUE TO SHAREOWNERS
MONSANTO QUARTERLY DIVIDENDS:
2001-2007
Dividends
STATUS
• Since establishment in 2001, Monsanto has increased dividends 6 times – an increase of 200 percent
Monsanto’s Strong Earnings Growth Continues To Be Reflected in Dividend Payout
9
$0.00
$0.02
$0.04
$0.06
$0.08
$0.10
$0.12
$0.14
$0.16
$0.18
$0.20
Jan-01 Jan-02 Jan-03 Jan-04 Jan-05 Jan-06 Jan-07 Jan-08
2007
Monsanto increases quarterly dividend twice in 12-month period
Per-
Sh
are
Am
ou
nts
1
EXTENDING LEADERSHIP
MONSANTO CAPITAL SPENDING:
2004-2007Capital Spending
STATUS
• Capital Spending is being used to support growth areas of the commercial business – supporting continued gross-profit growth
• Focus areas in 2008:• Global corn seed
production expansion to support share growth in DEKALB and ASI
• De-bottlenecking for glyphosate production to increase volumes
Expanded Capital Spending Supports Growth Areas of Current Commercial Business
10
$0
$100
$200
$300
$400
$500
$600
$700
$800
$900
$1,000
2004 2005 2006 2007 2008F
2008F
Increased Capital Spending used to support acceleration of corn-plant expansions and new
de-bottlenecking for glyphosate
$ in
th
ou
san
ds
1. Amounts for record dates from Jan. 1, 2001 – July 7, 2006 adjusted to allow comparison following Monsanto’s stock split
EXTENDING LEADERSHIP
Capital Spending
STATUS
• In June 2007, announced 3-year $610M plan to expand and build seed facilities in the U.S.
• In 2008, plan has been accelerated to reflect growth in DEKALB and ASI combined with continued growth expectations through 2012
• Outlook to 2012:• DEKALB to grow share
through 2012 by up to 10 points cumulatively from 2007 share of 23 percent
• Continued organic share growth in ASI
Primary Capital Spending Use For Acceleration of Corn Plant Expansions to Support DEKALB and ASI Share Growth
11
DEKALB AND ASI U.S. CORN SHARE EVOLUTION:
2001-2008F
10%
12%13%
14%
16%
20%
23%
9%
5%
4%
0%
5%
10%
15%
20%
25%
30%
2001 2002 2003 2004 2005 2006 2007 2008F
25 - 26%
10 - 11%
DEKALB Brand Share – U.S.
ASI Share – U.S.
2008F
Projecting 2-3% share gains for DEKALBand 1-2% share gains for ASI
GLOBAL VOLUME
(GALLONS):209M 215M 235M 252M 262M
BRANDED PRICE BAND
(PER GALLON):$11-$13 $11-$13 $11-$13 >$11-$13 $16-$18
TOTAL ROUNDUP AND ALL
OTHER GLYPHOSATE-BASED
HERBICIDES GROSS PROFIT:
$703M $637M $648M $854M $1.8B
EXTENDING LEADERSHIP
Capital Spending
STATUS
• In April, announced 18-month $196M de-bottlenecking plan
• Demand-driven environment is sustainable, with projection of $1.8B in gross profit in 2012
• Factors:• $16-$18 Branded price band
• Single-digit volume growth
• Increased capacity in CY2009-2010 from Monsanto
• Branded Roundup quality needed to service Roundup Ready opportunity
De-Bottlenecking of Roundup Production Moving to Increase Volumes to Meet Demand-Driven Opportunity
12
ROUNDUP AND OTHER GLYPHOSATE-BASED HERBICIDES:
BRANDED AND NON-BRANDED TRENDS – 2004-2008F
0
50
100
150
200
250
300
2004 2005 2006 2007 2008F
Glo
bal V
olu
me (
in g
allo
ns)
Branded
Non-Branded
EXTENDING TECHNOLOGY
R&D
STATUS
• Monsanto spends more on seed and biotech R&D than any other ag company
• R&D is targeted at 10% of sales
• >90% of R&D spend is for seeds-and-traits, split roughly 50/50 between breeding and biotechnology
• Outlook for 2008:• R&D spend likely to be in
9% range given rapid uptick in revenue, still greater than $850M
Monsanto’s Significant, But Focused R&D Investment Helps Extend Lead in Core Seeds-and-Traits Business
13
MONSANTO’S R&D EXPENDITURES:
2004-2007
Monsanto’s R&D spending applies earnings from established products like Roundup
herbicides to extend the company’s leadership in the high-margin seeds-and-traits
segment
$0
$100
$200
$300
$400
$500
$600
$700
$800
$900
2004 2005 2006 2007
0%
2%
4%
6%
8%
10%
12%
R&
D S
pen
d (
in $
millio
ns)
R&
D a
s P
erc
en
t of S
ale
s
EXTENDING TECHNOLOGY
R&D
STATUS
• Beyond pure R&D expense, Monsanto also uses cash for technology collaborations and other investments
• Monsanto has thousands of research agreements, licenses and collaborations with universities, institutes and other companies
Additional Spending for Collaborations and Other Investments Expand R&D Network
14
TECHNOLOGY SPEND FOR SEEDS & TRAITS1:
COLLABORATIONS AND INVESTMENTS – 2004-2007
$0
$10
$20
$30
$40
$50
$60
$70
2004 2005 2006 2007
$ in
millio
ns
1. Reflects portion of “Technology and Other Investments” devoted to seed-and-trait programs; 2006 figure excludes a one-time $100M payment made for patents for Monsanto’s Animal Agriculture business
15
EXTENDING TECHNOLOGY
R&D Engine Is Poised to Launch Average of One Game-Changing Technology Every Other Year Through Mid-Decade
2008 2009 2010 2011 2012 TO MID-DECADE
HIT Project
SmartStax
HIT Project
Nitrogen-Utilization Corn Family
TECHNOLOGY:
Roundup Ready 2 YieldSoybeans
Drought-Tolerant Corn Family
PRODUCT
CONCEPT:
• Resets trait platform for soybeans
• Resets trait platform in corn
• Value likely in improved yield under stress and potential for water replacement
• Targets ways to use nitrogen more efficiently
2020 COMMERCIAL
VALUE1:
HIGH HIGH HIGH HIGH
U.S. ACRE
OPPORTUNITY2:
40-50M 60-65M 55M 55M
STATUS:
• On track for controlled commercial release in 2009 of 1-2M acres
• Full commercial launch of 5-6M acres in 2010
• On track for 2010 launch
• Lead product in Phase 3 testing
• Second-generation product in Phase 2
• Lead product in Phase 1 testing
1. 2020 value reflects gross sales opportunity in launch country in year 2020; “HIGH” : $300-$500M
2. Acre opportunity reflects acres where technology fits at Monsanto's current 2007 market share in respective crops
DISCOVERY PHASE 1 PHASE 2 PHASE 3 PHASE 4
FAMILY TRAITS►
Broad-Acre, Higher-Yielding Family
HIGH
SOYBEANS:
BROAD-ACRE
YIELD
Broad-Acre, Higher-Yielding Family
Nitrogen-Utilization Family
FAMILY TRAITS►
FAMILY TRAITS► MEGA
HIGH
Drought-Tolerant Family
FAMILY TRAITS► HIGH
CORN:
BROAD-ACRE
YIELD
YIE
LD
&
S
TR
ES
S
CO
LL
AB
OR
AT
IO
N
High-oil
soybeans
Dicamba-tolerant soybeans
Vistive III
Improved-protein soybeans
Roundup Ready 2 Yield canola
Bollgard IIIOmega-3 soybeans
YieldGard VT PRO
corn
Roundup Ready 2 Yieldsoybeans
MEGA
>$1BM
HIGH
$300M-$500M
MID
$150M-$300M
Corn Soybeans Cotton Canola
2020 VALUE RANGES:
LOW
<$150M
Insect-protected RR2Y soybeans
Strong Pipeline Reflects Growing Innovation and Leadership; Expected to Create Commercial Value of $>5B in 2020
EXTENDING TECHNOLOGY
17
EXTENDING PLATFORMS
Recent Acquisitions Have Converted Cash From RoundupInto Higher-Margin Seed Opportunities
INVESTMENT OPPORTUNITY
In an expanding agriculture environment, value is defined by scarcity or innovation – Monsanto’s strategy is targeted on innovation: discovering and developing technology that is game-changing
CATEGORY EXAMPLES OUTLOOK
Intensify The Space ► Delta and Pine Land
► American Seeds, Inc. (ASI) Companies
► Agroeste (Brazil)
► De Ruiter Seeds (agreement signed)
• ASI and Delta and Pine Land moving to integration
• Leading position in protected-culture established in vegetables
• Continued opportunity for add-on international corn and vegetable seed companies
Strengthen position of the core business, largely by building the germplasm footprint of seeds
Expand The Space ► Seminis • Continually looking for areas where Monsanto can apply core technology quickly or benefit from advanced research
Expansion to adjacent spaces – where core technology can be applied quickly and with transformational benefits
Redefine The Space ► Yield and Stress R&D Collaboration with BASF
► SmartStax agreement with Dow
► Global Seed Treatment Alliances
• Most highly transformational, but rarest to find appropriate fitInvestments that rewrite the
landscape, providing new avenues, new technologies and creating new markets
ASI GROSS PROFIT PER ACRE
1
1.85
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
AV
ER
AG
E G
RO
SS
P
RO
FIT
/A
CR
E
(IN
DE
XE
D)
GP/acre increases 85% after ASI
acquisition
• With technology infusion, gross profit per acre lifts when seed company brought under ASI umbrella
Average GP/acre in same band as DEKALB
PRE-
ACQUISITION
POST-
ACQUISITIONDEKALB
EXTENDING PLATFORMS
Acquisitions
STATUS
• Begun in November 2004, ASI now stands at >20 seed brands
• With technology support of Monsanto and local touch of established brands, ASI is poised to grow 1-2 share points in 2008
Success of ASI Model Has Allowed Monsanto to Further Its Momentum in the U.S. Corn Business
19
VALUE CREATION FOR VEGETABLE SEED PLATFORM:
STAGED OPPORTUNITIES FOR INCREASING GROSS PROFIT
Focus on operational excellence; working capital management
VA
LU
E C
RE
AT
IO
N O
PP
OR
TU
NIT
Y
Assemble genetic maps for key crops
Identify and implement opportunities to capture full product value
Aggressively shift mix via protected culture and hybrid conversion
New product launches; use of molecular markers
2007 2008 2009 2010 2011 2012
2007
Monsanto vegetable
seed sales top
$600M in 2007; 7.5%
top-line growth2008
De Ruiter Seeds
acquisition agreement
announced1 – strengthens
protected-culture portfolio
2012
Monsanto vegetable
seeds projected to
be >$1B in sales,
mid-60s margin
2012
Molecular marker platform begins transforming
Seminis and De Ruiter portfolios
~2010
De Ruiter Seeds1 accretive to
Monsanto vegetable seed EPS
contribution in second full fiscal
year following closing
OPERATIONAL EXCELLENCE NEW VALUE CREATIONPIPELINE
ADVANCEMENT
De Ruiter Seeds Accelerates Monsanto Vegetable Seed Capability and Reach, Bolstering Five-Year Growth Prospects
EXTENDING PLATFORMS
1. Subject to closing
SUMMARY
MONSANTO WORKING CAPITAL:
2003-2007
Working Capital
STATUS
• Even as business expands, discipline has been sustained on key working capital elements
• 2007 Current Ratio – 1.65:1
• Focus in 2008:• Receivables as a percent
of sales: High teens
• Inventories as a percent of sales: 20%
Growth Is Underpinned By Financial Discipline, Continued Focus on Working Capital
20
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
2003 2004 2005 2006 2007
2007
Receivables and Inventories as a percent of sales decline to lowest point in Monsanto’s
existence
Perc
en
t o
f S
ale
s
Inventory as a percent of sales
Receivables as a percent of sales
Monsanto Using Strong Cash Backbone to Extend
Competitive Lead Through Innovation, Driving 2012 Growth
SUMMARY
$0
$2,000
$4,000
$6,000
$8,000
$10,000
2007 2008F 2012F
Seeds & Genomics
Roundup And Other Glyphosate-based Herbicides
All Other Agricultural Productivity
IN
M
ILLIO
NS
GROSS PROFIT OUTLOOK BY SEGMENT
2007-2012F
2012 GROWTH RANGE
Gross profit targeted to more than double from 2007 through 2012
STRATEGIC PLAYBOOK
All growth is organic, from
base business and pipeline
U.S. Corn International Corn Soybeans Cotton Vegetables R&D Pipeline
Earnings continue to translate into operating cash, and value created for shareowners through combination of acquisitions, share repurchases and dividends
>2X2007 BASELINE
Increased in Q2 2008 for
new Roundup target
Reconciliation of Non-GAAP Financial Measures
$ per shareFiscal Year
2008Fiscal
Year 2007Fiscal Year
2006Fiscal Year
2005Fiscal Year
2004Fiscal Year
2003
Net Income (Loss) per Share $3.38-$3.48 $1.79 $1.25 $0.47 $0.50 $0.13
Cumulative Effect of Change in Accounting Principle -- -- $0.01 -- -- $0.02
Diluted Earnings (Loss) per Share Before Effect of Accounting Change
$3.38-$3.48 $1.79 $1.26 $0.47 $0.50 $0.15
Solutia Claim Settlement ($0.23) -- -- -- -- --
Tax Charge on Repatriated Earnings -- -- $0.04 -- -- --
Seminis In-Process R&D -- -- -- $0.38 -- --
Solutia-Related Charge -- -- -- $0.32 -- --
Tax Benefit on Loss from European Wheat andBarley Business
-- -- -- $(0.19) -- --
Restructuring Charges -- Net -- -- -- $0.01 $0.18 $0.05
Loss (Income) on Discontinued Operations1 -- ($0.13) -- $0.05 -- $0.03
Impairment of Goodwill -- -- -- -- $0.12 --
In-Process R & D Write-Off Related to the Delta & Pine Land (D&PL) Acquisition
-- $0.34 -- -- -- --
PCB Litigation Settlement Expense – Net -- -- -- -- -- $0.48
Diluted Earnings (Loss) per Share from Ongoing Business $3.15-$3.25 $2.00 $1.30 $1.04 $0.80 $0.71
Reconciliation of Non-GAAP EPS
22
Note: EPS figures reflect the stock split effective July 28, 2006
1. The operating results of Stoneville and Nexgen have been conformed to discontinued operations for all relevant years presented.